Marilin Ivask
Overview
Explore the profile of Marilin Ivask including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yasar B, Boskovic N, Ivask M, Weltner J, Jouhilahti E, Vill P, et al.
BMC Genomics
. 2024 Nov;
25(1):1048.
PMID: 39506635
Background: Embryonic genome activation (EGA) is a critical step in early embryonic development, as it marks the transition from relying on maternal factors to the initiation of transcription from embryo's...
2.
Deligiannis S, Kask K, Modhukur V, Boskovic N, Ivask M, Jaakma U, et al.
J Assist Reprod Genet
. 2024 Feb;
41(4):1035-1055.
PMID: 38358432
Purpose: Ovarian tissue cryopreservation is vital for fertility preservation, yet its effect on ovarian tissue follicle survival and transcriptomic signature requires further investigation. This study delves into the effects of...
3.
Piibor J, Waldmann A, Dissanayake K, Andronowska A, Ivask M, Prasadani M, et al.
Mol Cell Proteomics
. 2023 Sep;
22(11):100642.
PMID: 37678639
Uterine environment is tightly and finely regulated via various signaling pathways mediated through endocrine, exocrine, autocrine, juxtacrine, and paracrine mechanisms. In utero signaling processes are paramount for normal and abnormal...
4.
Nomm M, Ivask M, Parn P, Reimann E, Koks S, Jaakma U
Genes (Basel)
. 2023 Mar;
14(3).
PMID: 36980841
Recent advances in preimplantation embryo diagnostics enable a wide range of applications using single cell biopsy and molecular-based selection techniques without compromising embryo production. This study was conducted to develop...
5.
Waszczykowska A, Zmyslowska A, Bartosiewicz K, Studzian M, Pulaski L, Braun M, et al.
Am J Ophthalmol
. 2021 Oct;
236:63-68.
PMID: 34710353
Purpose: To evaluate corneal sensitivity and corneal nerve morphology among patients with Wolfram syndrome (WFS). Design: An observational clinical case series with confirmatory experiments. Methods: We included a group of...
6.
Ivask M, Volke V, Raasmaja A, Koks S
Mol Genet Metab
. 2021 Jul;
134(1-2):203-211.
PMID: 34312071
Wolfram syndrome is a rare autosomal recessive disorder caused by mutations in the wolframin ER transmembrane glycoprotein (WFS1) gene and characterized by diabetes mellitus, diabetes insipidus, optic atrophy and deafness....
7.
Waszczykowska A, Zmyslowska A, Braun M, Ivask M, Koks S, Jurowski P, et al.
Diagnostics (Basel)
. 2020 Aug;
10(9).
PMID: 32824898
Background: Wolfram syndrome (WFS, OMIM: #222300) is an ultrarare autosomal recessive disorder characterized by diabetes insipidus, diabetes mellitus, optic nerve atrophy and deafness. It has been reported that the average...
8.
Waszczykowska A, Zmyslowska A, Braun M, Zielonka E, Ivask M, Koks S, et al.
Am J Ophthalmol
. 2020 Apr;
217:140-151.
PMID: 32335055
Purpose: To evaluate corneal morphology among patients with Wolfram syndrome (WFS). Design: Comparative observational longitudinal case series of WFS patients with a laboratory approach in the WFS1 gene knockout (Wfs1KO)...
9.
Eimre M, Paju K, Peet N, Kadaja L, Tarrend M, Kasvandik S, et al.
Oxid Med Cell Longev
. 2018 Dec;
2018:3175313.
PMID: 30584460
Wfs1 deficiency leads to a progressive loss of plasma insulin concentration, which should reduce the consumption of glucose in insulin-dependent tissues, causing a variety of changes in intracellular energy metabolism....
10.
Li D, Secher J, Hyttel P, Ivask M, Kolko M, Hall V, et al.
Cell Cycle
. 2018 Nov;
17(23):2547-2563.
PMID: 30457474
Physiologically and anatomically, humans and pigs share many similarities, which make porcine induced pluripotent stem cells (piPSCs) very attractive for modeling human cell therapy as well as for testing safety...